| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3317170 | Pancreatology | 2013 | 6 Pages |
Abstract
B7H4, DJ-1 and HSP27 may be used in the future as prognostic markers that express resistance of pancreatic cancer patients to chemotherapy with gemcitabine.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
A. Tsiaousidou, M. Lambropoulou, E. Chatzitheoklitos, G. Tripsianis, C. Tsompanidou, C. Simopoulos, A.K. Tsaroucha,